[
  {
    "ts": null,
    "headline": "Leading Multiple Myeloma Results Unveiled at ASH 2025: Paradigm-Shifting Data Redefines Treatment Landscape | DelveInsight",
    "summary": "The 67th American Society of Hematology (ASH) Annual Meeting, held December 6-9, 2025, in Orlando, Florida, showcased groundbreaking clinical advances in multiple myeloma treatment from leading biopharmaceutical companies. The conference featured unprecedented efficacy data demonstrating potential functional cures and innovative approaches across novel immunotherapies, bispecific antibodies, and next-generation targeted agents, signaling a major shift in how the disease is managed.",
    "url": "https://finnhub.io/api/news?id=6fdd21760a3d9cddf4caa3409f50674a1cbfac444dcdba2abccc6b56310ee9cd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765492260,
      "headline": "Leading Multiple Myeloma Results Unveiled at ASH 2025: Paradigm-Shifting Data Redefines Treatment Landscape | DelveInsight",
      "id": 137766873,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "The 67th American Society of Hematology (ASH) Annual Meeting, held December 6-9, 2025, in Orlando, Florida, showcased groundbreaking clinical advances in multiple myeloma treatment from leading biopharmaceutical companies. The conference featured unprecedented efficacy data demonstrating potential functional cures and innovative approaches across novel immunotherapies, bispecific antibodies, and next-generation targeted agents, signaling a major shift in how the disease is managed.",
      "url": "https://finnhub.io/api/news?id=6fdd21760a3d9cddf4caa3409f50674a1cbfac444dcdba2abccc6b56310ee9cd"
    }
  },
  {
    "ts": null,
    "headline": "3 Low-Volatility Stocks We’re Skeptical Of",
    "summary": "Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.",
    "url": "https://finnhub.io/api/news?id=8e921afd3fe92078bd81379162b5bd10e1e13254d879e01bd327f63071de72a6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765427878,
      "headline": "3 Low-Volatility Stocks We’re Skeptical Of",
      "id": 137756079,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.",
      "url": "https://finnhub.io/api/news?id=8e921afd3fe92078bd81379162b5bd10e1e13254d879e01bd327f63071de72a6"
    }
  }
]